Insider · CIK 0001555432
Thomas M. Botts
director
Files at NPO (Enpro Inc.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +82 | $306.26 | $25k | 18,153 | 11 d ago |
| Sep 16, 2026 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +17 | $287.16 | $4,882 | 18,068 | 25 d ago |
| Sep 16, 2026 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +3 | $287.16 | $953 | 18,072 | 25 d ago |
| Jun 18, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +25 | $185.86 | $4,647 | 17,841 | Jun 20, 2025 |
| Jun 18, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +5 | $185.86 | $917 | 17,846 | Jun 20, 2025 |
| Mar 19, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +26 | $175.76 | $4,570 | 17,811 | Mar 20, 2025 |
| Mar 19, 2025 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +5 | $175.76 | $915 | 17,816 | Mar 20, 2025 |
| Feb 13, 2025 | NPO Enpro Inc. | AGrant or award Common Stock | +685 | $182.27 | $125k | 9,140 | Feb 13, 2025 |
| Dec 18, 2024 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +25 | $175.86 | $4,397 | 17,780 | Dec 19, 2024 |
| Dec 18, 2024 | NPO Enpro Inc. | AGrant or award Phantom Stockderivative | +5 | $175.86 | $884 | 17,785 | Dec 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.